Literature DB >> 23086406

Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins.

Munir A Al-Zeer1, Hesham M Al-Younes, Daniel Lauster, Mohammad Abu Lubad, Thomas F Meyer.   

Abstract

Interferon γ (IFNG) is a key host response regulator of intracellular pathogen replication, including that of Chlamydia spp The antichlamydial functions of IFNG manifest in a strictly host, cell-type and chlamydial strain dependent manner. It has been recently shown that the IFNG-inducible family of immunity-related GTPases (IRG) proteins plays a key role in the defense against nonhost adapted chlamydia strains in murine epithelial cells. In humans, IFN-inducible guanylate binding proteins (hGBPs) have been shown to potentiate the antichlamydial effect of IFNG; however, how hGBPs regulate this property of IFNG is unknown. In this study, we identified hGBP1/2 as important resistance factors against C. trachomatis infection in IFNG-stimulated human macrophages. Exogenous IFNG reduced chlamydial infectivity by 50 percent in wild-type cells, whereas shRNA hGBP1/2 knockdown macrophages fully supported chlamydial growth in the presence of exogenous IFNG. hGBP1/2 were recruited to bacterial inclusions in human macrophages upon stimulation with IFNG, which triggered rerouting of the typically nonfusogenic bacterial inclusions for lysosomal degradation. Inhibition of lysosomal activity and autophagy impaired the IFNG-mediated elimination of inclusions. Thus, hGBP1/2 are critical effectors of antichlamydial IFNG responses in human macrophages. Through their capacity to remodel classically nonfusogenic chlamydial inclusions and stimulate fusion with autophagosomes, hGBP1/2 disable a major chlamydial virulence mechanism and contribute to IFNG-mediated pathogen clearance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086406      PMCID: PMC3542218          DOI: 10.4161/auto.22482

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  50 in total

1.  Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry.

Authors:  D G Mordue; L D Sibley
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

2.  Role of gamma interferon in controlling murine chlamydial genital tract infection.

Authors:  J I Ito; J M Lyons
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.

Authors:  S L Anderson; J M Carton; J Lou; L Xing; B Y Rubin
Journal:  Virology       Date:  1999-03-30       Impact factor: 3.616

4.  Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP.

Authors:  Y S Cheng; C E Patterson; P Staeheli
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells.

Authors:  C van Ooij; G Apodaca; J Engel
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes.

Authors:  L Koehler; E Nettelnbreker; A P Hudson; N Ott; H C Gérard; P J Branigan; H R Schumacher; W Drommer; H Zeidler
Journal:  Microb Pathog       Date:  1997-03       Impact factor: 3.738

7.  Secretion of proteins by Coxiella burnetii.

Authors:  T Redd; H A Thompson
Journal:  Microbiology       Date:  1995-02       Impact factor: 2.777

8.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response.

Authors:  V Redecke; K Dalhoff; S Bohnet; J Braun; M Maass
Journal:  Am J Respir Cell Mol Biol       Date:  1998-11       Impact factor: 6.914

Review 10.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12
View more
  50 in total

1.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

2.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 3.  Chlamydia cell biology and pathogenesis.

Authors:  Cherilyn Elwell; Kathleen Mirrashidi; Joanne Engel
Journal:  Nat Rev Microbiol       Date:  2016-04-25       Impact factor: 60.633

4.  Viral Replication Complexes Are Targeted by LC3-Guided Interferon-Inducible GTPases.

Authors:  Scott B Biering; Jayoung Choi; Rachel A Halstrom; Hailey M Brown; Wandy L Beatty; Sanghyun Lee; Broc T McCune; Erin Dominici; Lelia E Williams; Robert C Orchard; Craig B Wilen; Masahiro Yamamoto; Jörn Coers; Gregory A Taylor; Seungmin Hwang
Journal:  Cell Host Microbe       Date:  2017-06-29       Impact factor: 21.023

5.  The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases.

Authors:  Michael L Reese; Niket Shah; John C Boothroyd
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

Review 6.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

7.  Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence.

Authors:  Peng Li; Wei Jiang; Qin Yu; Wang Liu; Ping Zhou; Jun Li; Junjie Xu; Bo Xu; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

8.  Differential signaling pathways are initiated in macrophages during infection depending on the intracellular fate of Chlamydia spp.

Authors:  Uma M Nagarajan; Manoj Tripathy; Avinash Kollipara; John Allen; Anna Goodwin; Judy Whittimore; Priscilla B Wyrick; Roger G Rank
Journal:  Immunol Cell Biol       Date:  2018-01-06       Impact factor: 5.126

Review 9.  Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.

Authors:  Nathalie Britzen-Laurent; Christian Herrmann; Elisabeth Naschberger; Roland S Croner; Michael Stürzl
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

10.  Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death.

Authors:  Mary M Weber; Jennifer L Lam; Cheryl A Dooley; Nicholas F Noriea; Bryan T Hansen; Forrest H Hoyt; Aaron B Carmody; Gail L Sturdevant; Ted Hackstadt
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.